Related Experiment Video
Updated: Jan 6, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Targeting SHP-1 to alleviate testicular inflammation and apoptosis in a Poly(I:C)-induced orchitis model
Shimin Wang1, Jianing Tong2, Bicheng Jin3,4
1Prenatal Diagnosis Center, the Eighth Affiliated Hospital, Sun Yat-Sen University, No. 3025 Shennan Road, Shenzhen, 518033, China.
Abstract:
Orchitis, an inflammation of the testes primarily caused by viral infections such as mumps, presents a significant threat to male reproductive health. This study explores the role of Src homology 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1), a known tumor suppressor, in mitigating inflammation and apoptosis in testicular cells within a model of viral-induced orchitis. To simulate the immune response associated with viral orchitis, we utilized Poly (I:C), a synthetic analog of double-stranded RNA, which mimics the molecular patterns of viral RNA. This model provides a relevant framework for investigating immune responses in the testes triggered by viral-like stimuli. Our research aimed to elucidate the impact of SHP-1 expression on the inflammatory and apoptotic pathways activated during testicular inflammation. We found that Poly (I:C) induced significant inflammation and apoptosis in Leydig and Sertoli cells, characterized by reduced SHP-1 expression and elevated phosphorylated-STAT3 levels. Enhancing SHP-1 expression attenuated these inflammatory and apoptotic responses, whereas reactivating STAT3 with colivelin reversed the suppression of cytokine production and cell death. Moreover, inhibiting SHP-1 with TPI-1 treatment post-Poly (I:C) administration significantly exacerbated testicular inflammation and apoptosis, underscoring SHP-1's critical protective role. These findings highlight the therapeutic potential of targeting SHP-1 and STAT3 pathways in treating orchitis, advancing our understanding of the pathophysiology of testicular inflammation and suggesting new strategies for managing this condition.Author details: Please check if the designated corresponding authors affiliation is correctly identify and amend if necessary. Please see the attached file containing the updated author information for our manuscript. Author names: Please confirm if all the authors names are presented accurately and in the correct sequence. Kindly check and confirm whether the names of all authors has been processed correctly and amend if necessary. Please see the attached file containing the updated author information for our manuscript.
Insights
This study reveals that enhancing SHP-1 expression protects against viral orchitis by reducing testicular inflammation and apoptosis. Inhibiting SHP-1 worsens these conditions, highlighting its therapeutic potential.
Area of Science:
- Reproductive Biology
- Immunology
- Molecular Biology
Background:
- Orchitis, testicular inflammation often caused by viral infections, poses a risk to male reproductive health.
- Src homology 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1) is a tumor suppressor with potential anti-inflammatory roles.
- Viral infections trigger immune responses in testicular cells, leading to inflammation and apoptosis.
Purpose of the Study:
- To investigate the role of SHP-1 in viral-induced orchitis.
- To determine the impact of SHP-1 on inflammatory and apoptotic pathways in testicular cells.
- To explore potential therapeutic strategies targeting SHP-1 and STAT3.
Main Methods:
- Utilized Poly (I:C) to model viral-induced orchitis in testicular cells.
- Assessed SHP-1 expression, phosphorylated-STAT3 levels, inflammation, and apoptosis.
- Manipulated SHP-1 expression and STAT3 activity using pharmacological agents.
Main Results:
- Poly (I:C) induced testicular inflammation and apoptosis, correlating with reduced SHP-1 and elevated p-STAT3.
- Increased SHP-1 expression attenuated inflammation and apoptosis.
- STAT3 reactivation reversed SHP-1's protective effects; SHP-1 inhibition exacerbated orchitis.
Conclusions:
- SHP-1 plays a critical protective role against viral orchitis.
- Targeting SHP-1 and STAT3 pathways offers potential therapeutic avenues for orchitis treatment.
- Understanding SHP-1's function advances knowledge of testicular inflammation pathophysiology.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013